#zepbound

#zepbound

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.

The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication. [ more ]

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.

The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication. [ more ]

Medicare is forbidden from covering obesity drugs, but there is a bipartisan push to change that.

The cost of obesity drugs, such as Wegovy and Zepbound, is high, making them inaccessible to many. [ more ]

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.

Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo. [ more ]

Zepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage. [ more ]

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.

The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication. [ more ]

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.

Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo. [ more ]

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.

Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo. [ more ]

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.

Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo. [ more ]

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.

Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo. [ more ]

The popularity of anti-diabetes drugs repurposed for weight loss is increasing in the U.S.

The FDA approved Eli Lilly's Zepbound, which is the same as Mounjaro but used for weight loss instead. [ more ]